Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
Robert S. Hogg(Simon Fraser University), Julio Montaner(University of British Columbia), Michael V. O’Shaughnessy(Providence Health Care), Katherine Heath(University of British Columbia), Benita Yip(AIDS Vancouver), David R. Bangsberg(Simon Fraser University), Natasha Press(AIDS Vancouver)
Cited by 427
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies
|The Lancet|2008|1.7k
Impact of HIV‐related stigma on treatment adherence: systematic review and meta‐synthesis
|Journal of the International AIDS Society|2013|1.1k
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
|New England Journal of Medicine|2009|1.1k